Targeted drug outperforms chemotherapy for patients with hard-to-treat lung cancer
The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR exon ...
29 May 13:00 · Medical Xpress
Targeted therapy sunvozertinib outperforms standard chemotherapy in advanced lung cancer trial
The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR exon 20 insertion mutations (EGFR exon20ins), according to new research from The University of Texas MD Anderson Cancer Center.
29 May 18:29 · News-Medical
last updated on 29 May 20:11